SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
🧫

Metabolic Pathway-Targeted Therapy in ALS

active
experiment Created: 2026-04-02T17:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-als-meta
🌍 Provenance Graph 12 nodes, 52 edges

derives from (16)

▸ Show 11 more

supports (5)

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
523
Outgoing
435
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (957)
mentions📖PPARGC1A100%
mentions📖als100%
mentions📖PLIN2100%
mentions📖HK2100%
experiment_target📖HK2100%
derives_from📖Metabolic Pathway-Targeted Therapy in ALS95%
derives_from🧪Metabolic Switch Targeting for A1→A2 Repolarization90%
derives_from🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho90%
experiment_target🧪Perforant Path Presynaptic Terminal Protection Strategy90%
experiment_target🧪Digital Twin-Guided Metabolic Reprogramming90%
experiment_target🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho90%
derives_from🧪Metabolic Circuit Breaker via Lipid Droplet Modulation90%
experiment_target🧪Metabolic Circuit Breaker via Lipid Droplet Modulation90%
experiment_target🧪Metabolic Switch Targeting for A1→A2 Repolarization90%
derives_from🧪Digital Twin-Guided Metabolic Reprogramming90%
derives_from🧪Perforant Path Presynaptic Terminal Protection Strategy90%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho85%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation85%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization85%
related🧪Digital Twin-Guided Metabolic Reprogramming85%
related🧪Perforant Path Presynaptic Terminal Protection Strategy85%
mentions📖HK2 Protein — Hexokinase 280%
supports🧪Digital Twin-Guided Metabolic Reprogramming80%
supports🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho80%
supports🧪Perforant Path Presynaptic Terminal Protection Strategy80%
supports🧪Metabolic Circuit Breaker via Lipid Droplet Modulation80%
supports🧪Metabolic Switch Targeting for A1→A2 Repolarization80%
mentions📖PLIN2 Protein80%
mentions📖ALS Cure Roadmap70%
mentions📖GABA Imbalance in Neurodegeneration70%
mentions📖ALS Mechanistic Pathway70%
mentions📖PET Imaging in Neurodegeneration70%
mentions📖GABA-C Receptor Neurons70%
mentions📖GABA-A Gamma2 Neurons70%
mentions📖GABA-A Receptor Neurons70%
mentions📖ampk-activators70%
related📖HK2 Protein — Hexokinase 270%
mentions📖AMPK (AMP-Activated Protein Kinase)70%
mentions📖ALS Cure Roadmap70%
mentions📖ALS Failed Approaches Analysis70%
mentions📖GABA-A Receptor Alpha 1 Protein70%
mentions📖AMPK Activator Therapies70%
mentions📖MRI and Imaging Findings in Corticobasal Syndrome70%
mentions📖ALS Therapeutic Landscape — Programs by Phase and Modality70%
mentions📖ALS-FTD Spectrum: Unified Pathogenic Mechanisms70%
mentions📖GABA-A Beta3 Neurons70%
mentions📖ALS-FTD Overlap: Mechanistic Pathways70%
mentions📖GABA-B Receptor Subunit 2 — Protein70%
mentions📖ALS Knowledge Gaps Ranked List70%
mentions📖PPARGC1A Gene70%
mentions📖ALS Disease Spectrum vs Molecular Subtypes70%
mentions📖GABA (Gamma-Aminobutyric Acid) - Neurodegenerative Disease B70%
mentions📖ALS RNA Metabolism and Proteostasis Failure70%
mentions📖AMPK Alpha70%
mentions📖GABA Transporter Neurons in Inhibitory Transmission70%
mentions📖GABA-A Alpha-4 Protein — GABA-A Receptor Alpha 4 Subunit70%
mentions📖GABA<sub>A</sub> Receptor70%
mentions📖gaps-als-motor-neuron-vulnerability70%
related📖PLIN2 Gene70%
mentions📖gaps-als-immune-signature-stratification70%
related📖HK2 Protein — Hexokinase 270%
mentions📖ALS Trial Failure Analysis70%
mentions📖ALS Progression Trajectories70%
mentions📖AMPK Signaling Pathway70%
mentions📖ALS-FTD Spectrum70%
mentions📖GABA-A Receptor Beta 1 Subunit70%
mentions📖cell-types-gaba-receptors-neurod70%
mentions📖ALS Progression Rate Heterogeneity70%
mentions📖ALS Combination Therapy Matrix70%
mentions📖ALS Pipeline Companies70%
mentions📖GABA Receptor Modulation Therapy70%
related📖PGC-1α (PPARGC1A) Targeted Therapies in Neurodegeneration70%
mentions📖AMPK Signaling in Neurodegeneration70%
mentions📖GABA-B Receptor Neurons70%
mentions📖GABA-A Alpha2 Neurons70%
mentions📖GABA Transporter (GAT) Neurons70%
mentions📖ALS Treatment Overview70%
related📖PGC-1α (PPARGC1A)70%
mentions📖GABA Transporter 270%
mentions📖ALS Regional Onset and Spread: Network-Level Staging Model70%
mentions📖MRI for Neurodegenerative Diseases70%
mentions📖AMPK Signaling in Parkinson's Disease70%
mentions📖ALS-FTD Overlap Neurons70%
mentions📖AMPK Activators for Neurodegeneration — Investment Analysis70%
mentions📖ALS Association70%
mentions📖GABA-B Receptor Protein70%
mentions📖GABA Signaling Pathway70%
mentions📖GABA-A Alpha1 Neurons70%
mentions📖ALS Therapeutic Scorecard70%
mentions📖ALS Therapeutics70%
related📖als70%
mentions📖ALS vs FTD: Comparative Investment Analysis70%
mentions📖ALS Pipeline70%
mentions📖MRI Atrophy Patterns in CBS/PSP70%
related📖PGC-1α (PPARGC1A) Targeted Therapies in Neurodegeneration70%
mentions📖ALS Progression Rate Heterogeneity — mechanism and biomarker70%
mentions📖gaps-als-regional-onset-spread70%
mentions📖HK270%
mentions📖GABA-B Receptor Subunit 1 — Protein70%
mentions📖ALS Biomarker-to-Mechanism Mapping70%
mentions📖PET Imaging for Neurodegenerative Diseases70%
mentions📖GABA-A Alpha-5 Protein — GABA-A Receptor Alpha 5 Subunit70%
mentions📖PLIN2 Gene70%
mentions📖ALS Clinical Trials Consortium (NEALS)70%
mentions📖ALS-FTD-Parkinsonism Comparison Matrix70%
mentions📖gaps-als70%
mentions📖GABA-A Receptor Beta2 Protein70%
mentions📖AMPK Protein70%
mentions📖ALS Trial Failures Knowledge Gap70%
mentions📖gat370%
mentions📖GABA-A Receptor Epsilon Protein70%
mentions📖ALS Biomarkers and Disease Monitoring70%
related📖PPARGC1A Gene70%
related📖Packard Center for ALS Research70%
mentions📖GABA Receptor Modulation Therapy for Neurodegeneration70%
related📖HK270%
mentions📖PET Imaging Combined with Fluid Biomarkers70%
mentions📖GABA Transporter 170%
mentions📖AMPK Activators for Neurodegeneration70%
related📖PLIN2 Protein70%
mentions📖AMPK Agonist Therapy for Neurodegeneration70%
mentions📖GABA Receptors in Neuronal Inhibition70%
related📖PLIN2 Protein70%
mentions📖ALS Communication Brain-Computer Interfaces70%
mentions📖GABA-A Receptor Beta 1 Subunit70%
mentions📖GABA-A Receptor Theta (GABRQ) Protein70%
related📖PGC-1α (PPARGC1A)70%
mentions📖gaps-als-progression-rate-heterogeneity70%
mentions📖ALS Treatment Strategies70%
related📖AMPK Activators for Neurodegeneration — Investment Analysis63%
related📖PET Imaging in Neurodegeneration63%
related📖GABA-C Receptor Neurons63%
related📖GABA Transporter 163%
related📖GABA-A Receptor Theta (GABRQ) Protein63%
related📖ALS Therapeutic Landscape — Programs by Phase and Modality63%
related📖ALS-FTD Spectrum63%
related📖ALS Progression Rate Heterogeneity — mechanism and biomarker63%
related📖gaps-als63%
related📖PPARGC1A Gene63%
related📖GABA-A Alpha1 Neurons63%
related📖MRI Atrophy Patterns in CBS/PSP63%
related📖ALS-FTD Spectrum: Unified Pathogenic Mechanisms63%
related📖MRI and Imaging Findings in Corticobasal Syndrome63%
related📖AMPK Activators for Neurodegeneration63%
related📖ALS-FTD Overlap Neurons63%
related📖gaps-als-progression-rate-heterogeneity63%
related📖GABA Receptor Modulation Therapy for Neurodegeneration63%
related📖GABA-A Receptor Alpha 1 Protein63%
related📖GABA Transporter 263%
related📖AMPK Protein63%
related📖AMPK Signaling in Parkinson's Disease63%
related📖GABA Receptors in Neuronal Inhibition63%
related📖GABA-A Receptor Epsilon Protein63%
related📖ALS Treatment Overview63%
related📖gaps-als-motor-neuron-vulnerability63%
related📖AMPK Signaling Pathway63%
related📖ALS Biomarkers and Disease Monitoring63%
related📖GABA-A Alpha-4 Protein — GABA-A Receptor Alpha 4 Subunit63%
related📖GABA Receptor Modulation Therapy63%
related📖GABA<sub>A</sub> Receptor63%
related📖ALS Progression Rate Heterogeneity63%
related📖ALS Cure Roadmap63%
related📖GABA Transporter Neurons in Inhibitory Transmission63%
related📖GABA-B Receptor Protein63%
related📖ALS-FTD-Parkinsonism Comparison Matrix63%
related📖GABA (Gamma-Aminobutyric Acid) - Neurodegenerative Disease B63%
related📖gaps-als-immune-signature-stratification63%
related📖ALS Knowledge Gaps Ranked List63%
related📖AMPK Alpha63%
related📖ALS RNA Metabolism and Proteostasis Failure63%
related📖GABA-A Receptor Beta 1 Subunit63%
related📖ampk-activators63%
related📖ALS Therapeutic Scorecard63%
related📖GABA Imbalance in Neurodegeneration63%
related📖ALS Biomarker-to-Mechanism Mapping63%
related📖ALS Progression Trajectories63%
related📖ALS Mechanistic Pathway63%
related📖PLIN2 Gene63%
related📖AMPK Agonist Therapy for Neurodegeneration63%
related📖ALS Pipeline Companies63%
related📖ALS Therapeutics63%
related📖MRI for Neurodegenerative Diseases63%
related📖PET Imaging for Neurodegenerative Diseases63%
related📖ALS Association63%
related📖AMPK Activator Therapies63%
related📖ALS Communication Brain-Computer Interfaces63%
related📖cell-types-gaba-receptors-neurod63%
related📖ALS Pipeline63%
related📖gaps-als-regional-onset-spread63%
related📖AMPK Signaling in Neurodegeneration63%
related📖GABA Transporter (GAT) Neurons63%
related📖ALS Cure Roadmap63%
related📖GABA-B Receptor Subunit 1 — Protein63%
related📖ALS vs FTD: Comparative Investment Analysis63%
related📖GABA-A Beta3 Neurons63%
related📖GABA Signaling Pathway63%
related📖ALS Regional Onset and Spread: Network-Level Staging Model63%
related📖GABA-B Receptor Subunit 2 — Protein63%
related📖GABA-A Alpha2 Neurons63%
related📖GABA-B Receptor Neurons63%
related📖ALS Failed Approaches Analysis63%
related📖ALS-FTD Overlap: Mechanistic Pathways63%
related📖GABA-A Alpha-5 Protein — GABA-A Receptor Alpha 5 Subunit63%
related📖ALS Trial Failures Knowledge Gap63%
related📖HK263%
related📖GABA-A Receptor Beta 1 Subunit63%
related📖ALS Clinical Trials Consortium (NEALS)63%
related📖gat363%
related📖ALS Treatment Strategies63%
related📖ALS Combination Therapy Matrix63%
related📖AMPK (AMP-Activated Protein Kinase)63%
related📖PET Imaging Combined with Fluid Biomarkers63%
related📖GABA-A Gamma2 Neurons63%
related📖ALS Trial Failure Analysis63%
related📖GABA-A Receptor Neurons63%
related📖GABA-A Receptor Beta2 Protein63%
related📖ALS Disease Spectrum vs Molecular Subtypes63%
related📖Amylyx Pharmaceuticals, Inc.60%
related📖Neurologic Stem Cell Treatment Study for Progressive Supranu60%
related📖Tauraso (Nimodipine) ALS Trial60%
related📖Ion Channel Dysfunction in ALS60%
related📖Vascular Dementia Clinical Trials60%
related📖Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
related📖Healthcare Economics and Cost of Illness in Progressive Supr60%
related📖Pain Syndromes in Progressive Supranuclear Palsy60%
related📖VCP Proteostasis Modulation Therapy for ALS/FTD60%
related📖Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
related📖Progressive Supranuclear Palsy Neurons60%
related📖ALS-FTD-Parkinsonism Comparison Matrix60%
related📖Animal Models in Progressive Supranuclear Palsy Research60%
related📖Oligodendrocyte Dysfunction: AD vs PD vs ALS vs FTD vs HD Co60%
related📖AAIC 2026: Prevention Trials60%
related📖C9orf72 Repeat Expansion in ALS60%
related📖Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related📖ALS Biomarkers and Disease Monitoring60%
related📖Nigral Microglia in Progressive Supranuclear Palsy60%
related📖Linked Clinical Trials (Cure Parkinson's)60%
mentions📖Mitochondria60%
related📖CBS/PSP Clinical Trials Guide60%
mentions📖biomarkers60%
related📖Cortical GABAergic Interneurons in Amyotrophic Lateral Scler60%
related📖Tau Aggregation Mechanisms in Progressive Supranuclear Palsy60%
related📖Acumen Pharmaceuticals, Inc.60%
related📖Lupin Pharmaceuticals60%
related📖Autophagy Failure Comparison -- AD/PD/ALS/FTD/HD60%
related📖Central Vestibular Pathway Vulnerability in Progressive Supr60%
related📖Ionis Pharmaceuticals60%
related📖Upper Motor Neurons in Amyotrophic Lateral Sclerosis60%
mentions📖glutamate60%
related📖Axonal Transport Dysfunction in Progressive Supranuclear Pal60%
mentions📖Astrocytes60%
related📖ALS4 Protein (Alsin)60%
related📖Idorsia Pharmaceuticals Ltd.60%
related📖mTOR Signaling Dysregulation in Progressive Supranuclear Pal60%
related📖Non-Cell-Autonomous Glial Pathways in ALS60%
related📖neuroinflammation-ad-pd-als60%
related📖Circadian Dysfunction and Melatonin Alterations in Progressi60%
related📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain60%
related📖Amyotrophic Lateral Sclerosis (ALS) Treatment60%
related📖Neuroimmune Biomarkers in Progressive Supranuclear Palsy60%
related📖Sporadic ALS Initiation Mechanisms60%
related📖C9orf72→RNA/Dipeptide Repeat Pathology→ALS/FTD — Causal Chai60%
related📖FUS Protein-Targeting Therapy for ALS/FTD60%
related📖Transcranial Magnetic Stimulation in Progressive Supranuclea60%
related📖Rapamycin ALS Trial - mTOR Inhibition for Amyotrophic Latera60%
related📖Nigrostriatal Dopamine Terminals in Parkinson's Disease60%
related📖Edaravone ALS Trial60%
related📖ALS RNA Metabolism and Proteostasis Failure60%
related📖Progressive Supranuclear Palsy (PSP) Pathway60%
related📖ALS Pipeline Companies60%
related📖Creatine ALS Trial60%
related📖PD Clinical Trials — MDS 202660%
related📖Regeneron Pharmaceuticals60%
related📖Masitinib ALS Trial60%
related📖Progressive Supranuclear Palsy60%
related📖Quality of Life and Caregiver Burden in Progressive Supranuc60%
related📖Sargramostim (GM-CSF) ALS Trial60%
related📖ALS vs FTD: Comparative Investment Analysis60%
related📖Neuropathology of Progressive Supranuclear Palsy60%
related📖Spinal Cord Astrocytes in ALS60%
related📖Lower Motor Neurons in ALS with C9orf7260%
related📖ALS Combination Therapy Matrix60%
related📖Treatment Approaches for Amyotrophic Lateral Sclerosis (ALS)60%
related📖Gait and Balance Disorders in Progressive Supranuclear Palsy60%
related📖ALS Progression Trajectories60%
related📖ARO-MAPT-SC Tau ASO Trial (NCT07221344) - Arrowhead Pharmace60%
related📖Ironwood Pharmaceuticals60%
related📖Emerging Clinical Trials in Neurodegenerative Diseases60%
related📖Vascular and Endothelial Dysfunction in Progressive Supranuc60%
related📖Astrocytic Pathology in Progressive Supranuclear Palsy60%
related📖AAIC 2026: Biomarker-Guided Clinical Trials60%
related📖Local Field Potentials of Subthalamic Nucleus in Parkinson&#60%
related📖ALS9 - Amyotrophic Lateral Sclerosis 960%
related📖Oligodendroglial Involvement in Progressive Supranuclear Pal60%
related📖Senolytic Therapies for CBS and [PSP](/diseases/progressive-60%
related📖Healey Center for ALS60%
related📖ALS2 (Alsin)60%
related📖Exosome-Mediated Tau Propagation in Progressive Supranuclear60%
related📖Computational Tau Spreading Models in Progressive Supranucle60%
related📖ALS-FTD Spectrum: Unified Pathogenic Mechanisms60%
related📖Metabolomic Alterations in Progressive Supranuclear Palsy60%
related📖Lysosomal Dysfunction in Progressive Supranuclear Palsy60%
related📖SOD1 Superoxide Dismutase 1 ALS Causal Chain60%
related📖SfN 2026: ALS and Motor Neuron Disease Sessions60%
related📖Pre-symptomatic Conversion Windows in ALS Genetic Risk Carri60%
related📖Anji Pharmaceuticals60%
related📖ALS Progression Rate Heterogeneity60%
related📖ALS Mechanistic Pathway60%
related📖Alsin (ALSIN)60%
related📖Proteomics of Progressive Supranuclear Palsy60%
related📖Gender Differences in Progressive Supranuclear Palsy60%
related📖ALS Communication Brain-Computer Interfaces60%
related📖Substantia Nigra Neurons in Progressive Supranuclear Palsy60%
related📖Subthalamic Nucleus Neurons in Progressive Supranuclear Pals60%
related📖Assistive Technology and Devices for Progressive Supranuclea60%
related📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy60%
related📖TDP-43 DNA Repair Mechanism in ALS and Dementia60%
related📖D-Cycloserine ALS Trial60%
related📖Spinal Cord Motor Neurons in Amyotrophic Lateral Sclerosis60%
related📖Epigenetic Dysregulation Comparison -- AD/PD/ALS/FTD/HD60%
related📖Autophagy Dysfunction in Progressive Supranuclear Palsy60%
related📖Disease Progression and Staging in Progressive Supranuclear 60%
related📖Progressive Supranuclear Palsy (PSP) Treatment60%
related📖SOD1-Targeting Therapies for ALS60%
related📖Speech and Voice Disorders in Progressive Supranuclear Palsy60%
related📖Cortical Involvement and Neurodegeneration in Progressive Su60%
mentions📖Metabolic Pathway-Targeted Therapy in ALS60%
related📖Myelin Pathology Disease Comparison — AD/PD/ALS/FTD/HD60%
related📖Microglia Dysfunction: AD vs PD vs ALS vs FTD vs HD Comparis60%
related📖Alsin Protein60%
related📖Lipid Metabolism Dysfunction Comparison — AD/PD/ALS/FTD/HD60%
related📖Motor Cortex in Amyotrophic Lateral Sclerosis60%
related📖Arrowhead Pharmaceuticals60%
related📖Exosome-Mediated Tau Propagation in Progressive Supranuclear60%
related📖nimodipine-als60%
related📖Neuroinflammation Across AD, PD, ALS, FTD, and HD60%
related📖Epigenetics in Amyotrophic Lateral Sclerosis60%
related📖Proteasome Dysfunction in Progressive Supranuclear Palsy60%
related📖Mossy Fiber Terminals60%
related📖Packard Center for ALS Research60%
related📖Neuroimaging in Progressive Supranuclear Palsy60%
related📖ALS Trial Failures Knowledge Gap60%
related📖Metabolic Dysfunction and Insulin Resistance in Progressive 60%
related📖Inflammatory Astrocytes in ALS60%
related📖Recursion Pharmaceuticals60%
related📖Minocycline ALS Trial60%
related📖TBK1-Mediated Neuroinflammation Hypothesis — Autophagy Failu60%
related📖C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
related📖ALS8 - Amyotrophic Lateral Sclerosis 860%
related📖Mitochondrial Dysfunction in Progressive Supranuclear Palsy60%
related📖ALS Failed Approaches Analysis60%
related📖Progressive Supranuclear Palsy (PSP)60%
related📖Spinal Cord Motor Neurons in Amyotrophic Lateral Sclerosis60%
related📖Sodium Phenylbutyrate/Taurursodiol (Relyvrio) for ALS60%
related📖ALS Association60%
related📖Spinal Cord Neurons in Amyotrophic Lateral Sclerosis60%
related📖ALS Therapeutic Scorecard60%
related📖Synaptic Dysfunction in Progressive Supranuclear Palsy60%
related📖Lithium Continuation in ALS Trial60%
related📖LGALS1 Protein — Galectin-160%
mentions📖hypotheses60%
mentions📖Astrocytes60%
related📖Vestibular Dysfunction in Progressive Supranuclear Palsy60%
related📖TBK1-Mediated Neuroinflammation Hypothesis — Impaired Autoph60%
related📖viral-post-infectious-als60%
related📖Tau Aggregate Specificity in Progressive Supranuclear Palsy60%
related📖Anti-Amyloid Antibody Clinical Trials60%
related📖ALS Disease Spectrum vs Molecular Subtypes60%
related📖ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related📖ALSINC Protein - ALS IncRNA60%
related📖Vanda Pharmaceuticals60%
related📖ALS Cure Roadmap60%
related📖CSF Biomarkers for Corticobasal Syndrome and Progressive Sup60%
related📖Perineuronal Net Dysfunction in Progressive Supranuclear Pal60%
related📖CHCHD10 Mitochondrial Dysfunction — ALS/FTD Causal Chain60%
related📖CNversyt and Megan Rodden ALS Trials60%
related📖ALS Pipeline60%
related📖Calcium Dysregulation in Progressive Supranuclear Palsy60%
related📖Nigrostriatal Dopamine Terminals in Parkinson Disease60%
related📖TDP-43 Pathology Reversibility in ALS60%
related📖PTPσ (PTPRS) in C9ORF72-ALS/FTD - PI3P Regulation Mechanism60%
related📖Valproic Acid Trial Failure in Progressive Supranuclear Pals60%
related📖Acadia Pharmaceuticals60%
related📖ALS4 Protein (Alsine)60%
related📖FNP-223 PROSPER Trial - Phase 2 in Progressive Supranuclear 60%
related📖Failed Alzheimer's Disease Clinical Trials Analysis60%
related📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi60%
related📖Brain-Computer Interface for Progressive Supranuclear Palsy60%
related📖Progressive Bulbar Palsy (PBP)60%
related📖UCB0107 for Progressive Supranuclear Palsy60%
related📖Environmental Exposure Causal Attribution in ALS — Experimen60%
related📖ALSENLITE: Senolytics Trial for AD (NCT04785300)60%
related📖Sleep and Circadian Disorders in Progressive Supranuclear Pa60%
related📖Progressive Supranuclear Palsy (PSP) Investment Landscape60%
related📖Guam Parkinsonism-Dementia Complex (ALS-PDC)60%
related📖Stress Granule Homeostasis in ALS/FTD60%
related📖Relyvrio (Sodium Phenylbutyrate/Taurursodiol) for ALS60%
related📖Tau Oligomer Biology in Progressive Supranuclear Palsy60%
related📖High-Dose Vitamins ALS Trial60%
related📖Neuroinflammation in Progressive Supranuclear Palsy60%
related📖C9orf72-ALS Network60%
related📖ALS Regional Onset and Spread: Network-Level Staging Model60%
related📖Imaging Biomarkers for Corticobasal Syndrome and Progressive60%
related📖Presynaptic Terminals in Neurodegeneration60%
related📖Purinergic Receptor Targeted Trials in Parkinson's Dise60%
related📖atl1103-antisense-als60%
related📖Intravenous Immunoglobulin (IVIG) in ALS Trial60%
related📖C9orf72 Hexanucleotide Repeat Expansion Pathway in ALS and F60%
related📖Dipeptide Repeat Proteins (DPRs) in C9orf72-ALS/FTD60%
related📖Neuroinflammation Comparison — AD/PD/ALS/FTD/HD60%
related📖ALS Cure Roadmap60%
related📖Sleep-Disordered Breathing in Progressive Supranuclear Palsy60%
related📖FUS Gene-Mechanism-Therapy Causal Chain — ALS/FTD60%
related📖Typhaneoside for Progressive Supranuclear Palsy60%
related📖Alsin Protein (ALS2)60%
mentions📖neuroimaging60%
mentions📖events60%
related📖ALS Trial Failure Analysis60%
related📖ALS Treatment Strategies60%
related📖LY-3372689 LOTUS Trial - Phase 2 in Progressive Supranuclear60%
related📖LGALS3 Gene60%
related📖TDP-43 Proteinopathy in ALS60%
related📖Ceftriaxone ALS Trial60%
related📖Patricia Martinez — PSP Clinical Trials Researcher60%
related📖Locus Coeruleus Noradrenergic in Progressive Supranuclear Pa60%
related📖c9orf72-als-ftd-phenotype-mechanism60%
related📖AAIC 2026: Clinical Trials and Drug Development60%
related📖ALS10 - Amyotrophic Lateral Sclerosis 10 (TARDBP)60%
related📖Veterinary Tauopathies in Progressive Supranuclear Palsy Res60%
related📖TPN-101 for Progressive Supranuclear Palsy60%
related📖Noradrenergic Dysfunction in Progressive Supranuclear Palsy60%
related📖LGALS1 — Galectin-160%
related📖Pyroptosis and Inflammasome Activation in Progressive Supran60%
related📖Astrocytes in ALS60%
related📖ALS7 - Amyotrophic Lateral Sclerosis 760%
related📖Pupillary and Visual Dysfunction in Progressive Supranuclear60%
related📖Motor Neuron Vulnerability in ALS60%
related📖Mitochondrial Complex I Dysfunction in Progressive Supranucl60%
related📖InnoCan Pharmaceuticals Ltd.60%
related📖PGC-1α Mitochondrial Biogenesis Comparison — AD/PD/ALS/FTD/H60%
related📖NeuroMit Pharmaceuticals60%
related📖Gabapentin ALS Trial60%
related📖Vestibular-Ocular Reflex Deficits in Progressive Supranuclea60%
related📖Promising Clinical Trials in Neurodegenerative Diseases60%
related📖Motor Neurons in ALS and Frontotemporal Dementia60%
related📖ALSINC — ALS IncRNA60%
related📖Progressive Supranuclear Palsy Diagnostic Methods60%
related📖Riluzole ALS Trials60%
related📖Amyotrophic Lateral Sclerosis (ALS) Investment Landscape60%
related📖Calsyntenin 160%
related📖ALS Knowledge Gaps Ranked List60%
related📖scineuro-pharmaceuticals60%
related📖mTOR Signaling Dysregulation in Progressive Supranuclear Pal60%
related📖Progressive Supranuclear Palsy Investment Landscape60%
related📖ALS Therapeutics60%
related📖TauRx Pharmaceuticals60%
related📖Astrocyte Dysfunction: AD vs PD vs ALS vs FTD vs HD Comparis60%
related📖OPTN (Optineurin) Mitophagy Dysfunction — ALS/FTD/PD Causal 60%
mentions📖experiments60%
related📖Clinical Trials in Progressive Supranuclear Palsy60%
related📖Heat Shock Protein Dysfunction in Progressive Supranuclear P60%
related📖Investment Landscape: ALS60%
related📖Iron Accumulation in Progressive Supranuclear Palsy60%
related📖Eye Tracking and Saccade Testing in Progressive Supranuclear60%
related📖Cytoskeleton Dysfunction Comparison -- AD/PD/ALS/FTD/HD60%
related📖clinical-trials60%
related📖PI3K/Akt Activator Clinical Trials for Parkinson's Dise60%
related📖Autonomic Dysfunction in Progressive Supranuclear Palsy60%
related📖Neural Circuits in Progressive Supranuclear Palsy60%
related📖Polyneuron Pharmaceuticals AG60%
related📖Computational Models of Tau Propagation in Progressive Supra60%
related📖Low-Dose Naltrexone ALS Trial60%
related📖Tau Propagation and Seeding in Progressive Supranuclear Pals60%
related📖Alnylam Pharmaceuticals60%
related📖Brainstem Reflex Dysfunction in Progressive Supranuclear Pal60%
related📖Shanghai Pharmaceuticals60%
related📖Master Screening Study to Determine Individuals With Potenti60%
related📖als260%
related📖Sporadic ALS Initiation Mechanisms60%
related📖Nigrostriatal Dopamine Terminals in Parkinson's Disease60%
related📖progressive-supranuclear-palsy-tauopathy60%
related📖Sigma-Tau Pharmaceuticals60%
related📖amiloride-als60%
related📖Linked Clinical Trials Program60%
related📖CurePSP - Foundation for Progressive Supranuclear Palsy60%
related📖Neurotransmitter Dysfunction in Progressive Supranuclear Pal60%
related📖Lithium Carbonate in Amyotrophic Lateral Sclerosis60%
related📖Blood-Brain Barrier Dysfunction: AD vs PD vs ALS Comparison60%
related📖Edmond J Safra Accelerating Clinical Trials in Parkinson60%
related📖Mitochondrial Dysfunction in ALS-FTD Spectrum60%
related📖TDP-43 PET Ligand Development for FTD and ALS60%
related📖ALS Therapeutic Landscape — Programs by Phase and Modality60%
related📖TREM2 in ALS60%
related📖MitoRestore Pharmaceuticals60%
related📖ALS-FTD Spectrum60%
related📖Oculomotor Neurons in Amyotrophic Lateral Sclerosis60%
related📖Spinal Cord V2a Interneurons in ALS60%
related📖JCR Pharmaceuticals60%
related📖Progressive Supranuclear Palsy (PSP) Treatment Guide60%
related📖Betz Cells in Amyotrophic Lateral Sclerosis60%
related📖AMX0035 for Progressive Supranuclear Palsy60%
related📖ALSENLITE: Senolytics for Alzheimer's Disease Trial60%
related📖Globus Pallidus Neurons in Progressive Supranuclear Palsy60%
related📖ALS2 Protein (Alsin)60%
related📖Rehabilitation and Management of Progressive Supranuclear Pa60%
related📖Metabolic Pathway-Targeted Therapy in ALS60%
related📖Ferroptosis Disease Comparison — AD/PD/ALS/FTD/HD60%
related📖ALS Treatment Overview60%
related📖Olfactory Dysfunction in Progressive Supranuclear Palsy60%
mentions📖riluzole60%
related📖Genetics of Progressive Supranuclear Palsy60%
related📖Progressive Supranuclear Palsy Neural Circuit60%
related📖Myelin Pathology in Progressive Supranuclear Palsy60%
related📖Motor Neurons in C9orf72-Linked ALS/FTD60%
related📖lgals3-protein60%
related📖Environmental Risk Factors in Progressive Supranuclear Palsy60%
related📖mitochondrial-dysfunction-als60%
related📖Pedunculopontine Nucleus Cholinergic in Progressive Supranuc60%
related📖Selective Neuronal Vulnerability in Progressive Supranuclear60%
related📖Progressive Supranuclear Palsy Treatment Landscape60%
related📖SOD1 ALS Pathway60%
related📖Neuromelanin Loss in Progressive Supranuclear Palsy60%
related📖Clinical Trials in Parkinson's Disease60%
related📖Amyotrophic Lateral Sclerosis (ALS) Genetic Variants60%
related📖Supernus Pharmaceuticals60%
related📖AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi60%
related📖Speech and Swallowing Disorders in Progressive Supranuclear 60%
related📖Ribosomal and Translation Dysfunction in Progressive Supranu60%
related📖FTLD-ALS: Frontotemporal Lobar Degeneration with Motor Neuro60%
related📖CTAD 2026 — Clinical Trials on Alzheimer's Disease60%
related📖Biomarkers for Progressive Supranuclear Palsy60%
related📖ALS-FTD Overlap Neurons60%
related📖FTD-ALS Spectrum60%
related📖Cognitive Impairment in Progressive Supranuclear Palsy60%
related📖Acumen Pharmaceuticals60%
related📖Guam ALS-Parkinsonism-Dementia Complex (ALS-PDC)60%
related📖C9orf72 Hexanucleotide Repeat Expansion Pathway in ALS60%
related📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy60%
related📖VCP→TDP-43→ALS/FTD Causal Chain60%
related📖ALS Biomarker-to-Mechanism Mapping60%
related📖Clinical Trials Dashboard60%
related📖Sleep and Respiratory Network Interaction in ALS — Experimen60%
related📖FUS Proteinopathy Pathway in ALS60%
related📖Neurovascular Coupling Disease Comparison — AD/PD/ALS/FTD/HD60%
related📖Araim Pharmaceuticals60%
related📖ALS-FTD Overlap: Mechanistic Pathways60%
related📖Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related📖ALS Clinical Trials Consortium (NEALS)60%
related📖Ocular Motor Dysfunction in Progressive Supranuclear Palsy60%
related📖als460%
related📖Antisense Oligonucleotide Therapy for C9orf72 ALS/FTD60%
related📖Brain Network Connectivity Changes in Progressive Supranucle60%
related📖FNP-223 PROSPER Trial - Phase 2 in Progressive Supranuclear 60%
related📖AAN 2026 Clinical Trials60%
related📖Idebenone ALS Trial60%
related📖Purkinje Cell Axonal Terminals60%
related📖Epigenetic Changes in Progressive Supranuclear Palsy60%
related📖ER Stress and Unfolded Protein Response in Progressive Supra60%
related📖Autophagy-Lysosomal Impairment Comparison — AD/PD/ALS/FTD/HD60%
related📖Nacuity Pharmaceuticals60%
related📖Central Vestibular Pathway Vulnerability in Progressive Supr60%
related📖BCI Clinical Trials for Neurodegenerative Diseases60%
related📖Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
related📖Progressive Supranuclear Palsy - Richardson Syndrome60%
related📖Neuropsychiatric Symptoms in Progressive Supranuclear Palsy60%
related📖Amyotrophic Lateral Sclerosis (ALS)60%
related📖Bulbar Palsy60%
related📖Vertex Pharmaceuticals60%
related📖Spatial Transcriptomics of Progressive Supranuclear Palsy60%
related📖Acoramidis Clinical Trials60%
related📖Sodium Phenylbutyrate ALS Trial60%
mentions📖C9orf72 Repeat Expansion in ALS55%
mentions📖FTLD-ALS: Frontotemporal Lobar Degeneration with Motor Neuro55%
mentions📖Sporadic ALS Initiation Mechanisms55%
mentions📖Progressive Supranuclear Palsy55%
mentions📖Guam ALS-Parkinsonism-Dementia Complex (ALS-PDC)55%
mentions📖FTD-ALS Spectrum55%
mentions📖Investment Landscape: ALS55%
mentions📖Healthcare Economics and Cost of Illness in Progressive Supr55%
mentions📖Neuropsychiatric Symptoms in Progressive Supranuclear Palsy55%
mentions📖Quality of Life and Caregiver Burden in Progressive Supranuc55%
mentions📖Gender Differences in Progressive Supranuclear Palsy55%
mentions📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi55%
mentions📖Progressive Supranuclear Palsy - Richardson Syndrome55%
mentions📖Genetics of Progressive Supranuclear Palsy55%
mentions📖Progressive Supranuclear Palsy (PSP)55%
mentions📖Amyotrophic Lateral Sclerosis (ALS) Genetic Variants55%
mentions📖Cognitive Impairment in Progressive Supranuclear Palsy55%
mentions📖Amyotrophic Lateral Sclerosis (ALS)55%
mentions📖Progressive Bulbar Palsy (PBP)55%
mentions📖Guam Parkinsonism-Dementia Complex (ALS-PDC)55%
mentions📖Pupillary and Visual Dysfunction in Progressive Supranuclear55%
related📖PI3K/Akt Activator Clinical Trials for Parkinson's Dise54%
related📖Gait and Balance Disorders in Progressive Supranuclear Palsy54%
related📖Progressive Supranuclear Palsy Neural Circuit54%
related📖Epigenetic Changes in Progressive Supranuclear Palsy54%
related📖neuroimaging54%
related📖TBK1-Mediated Neuroinflammation Hypothesis — Impaired Autoph54%
related📖Ribosomal and Translation Dysfunction in Progressive Supranu54%
related📖TPN-101 for Progressive Supranuclear Palsy54%
related📖NeuroMit Pharmaceuticals54%
related📖Autophagy-Lysosomal Impairment Comparison — AD/PD/ALS/FTD/HD54%
related📖Failed Alzheimer's Disease Clinical Trials Analysis54%
related📖Quality of Life and Caregiver Burden in Progressive Supranuc54%
related📖Computational Models of Tau Propagation in Progressive Supra54%
related📖Amyotrophic Lateral Sclerosis (ALS) Investment Landscape54%
related📖Neuroinflammation Across AD, PD, ALS, FTD, and HD54%
related📖Mitochondrial Dysfunction in Progressive Supranuclear Palsy54%
related📖Perineuronal Net Dysfunction in Progressive Supranuclear Pal54%
related📖Arrowhead Pharmaceuticals54%
related📖Neurologic Stem Cell Treatment Study for Progressive Supranu54%
related📖Antisense Oligonucleotide Therapy for C9orf72 ALS/FTD54%
related📖SOD1 ALS Pathway54%
related📖Nigrostriatal Dopamine Terminals in Parkinson's Disease54%
related📖Spatial Transcriptomics of Progressive Supranuclear Palsy54%
related📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain54%
related📖AAIC 2026: Biomarker-Guided Clinical Trials54%
related📖Spinal Cord Neurons in Amyotrophic Lateral Sclerosis54%
related📖Nigral Microglia in Progressive Supranuclear Palsy54%
related📖Healey Center for ALS54%
related📖Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related📖InnoCan Pharmaceuticals Ltd.54%
related📖AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi54%
related📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi54%
related📖Polyneuron Pharmaceuticals AG54%
related📖Acumen Pharmaceuticals54%
related📖Central Vestibular Pathway Vulnerability in Progressive Supr54%
related📖Mitochondrial Dysfunction in ALS-FTD Spectrum54%
related📖Clinical Trials Dashboard54%
related📖Lupin Pharmaceuticals54%
related📖Neurotransmitter Dysfunction in Progressive Supranuclear Pal54%
related📖SOD1 Superoxide Dismutase 1 ALS Causal Chain54%
related📖Amyotrophic Lateral Sclerosis (ALS) Genetic Variants54%
related📖ALS7 - Amyotrophic Lateral Sclerosis 754%
related📖Motor Neurons in C9orf72-Linked ALS/FTD54%
related📖Acadia Pharmaceuticals54%
related📖Neuroimmune Biomarkers in Progressive Supranuclear Palsy54%
related📖LY-3372689 LOTUS Trial - Phase 2 in Progressive Supranuclear54%
related📖Nigrostriatal Dopamine Terminals in Parkinson's Disease54%
related📖riluzole54%
related📖TDP-43 Proteinopathy in ALS54%
related📖Sigma-Tau Pharmaceuticals54%
related📖Astrocytes in ALS54%
related📖Calsyntenin 154%
related📖neuroinflammation-ad-pd-als54%
related📖Progressive Supranuclear Palsy (PSP) Investment Landscape54%
related📖Sleep and Circadian Disorders in Progressive Supranuclear Pa54%
related📖Alsin Protein54%
related📖TREM2 in ALS54%
related📖Sleep-Disordered Breathing in Progressive Supranuclear Palsy54%
related📖TBK1-Mediated Neuroinflammation Hypothesis — Autophagy Failu54%
related📖Eye Tracking and Saccade Testing in Progressive Supranuclear54%
related📖Assistive Technology and Devices for Progressive Supranuclea54%
related📖ALS4 Protein (Alsine)54%
related📖LGALS1 — Galectin-154%
related📖Autophagy Failure Comparison -- AD/PD/ALS/FTD/HD54%
related📖Progressive Bulbar Palsy (PBP)54%
related📖UCB0107 for Progressive Supranuclear Palsy54%
related📖Progressive Supranuclear Palsy Diagnostic Methods54%
related📖High-Dose Vitamins ALS Trial54%
related📖Cortical Involvement and Neurodegeneration in Progressive Su54%
related📖Senolytic Therapies for CBS and [PSP](/diseases/progressive-54%
related📖Exosome-Mediated Tau Propagation in Progressive Supranuclear54%
related📖Purkinje Cell Axonal Terminals54%
related📖Amyotrophic Lateral Sclerosis (ALS) Treatment54%
related📖Minocycline ALS Trial54%
related📖Guam ALS-Parkinsonism-Dementia Complex (ALS-PDC)54%
related📖Epigenetic Dysregulation Comparison -- AD/PD/ALS/FTD/HD54%
related📖Microglia Dysfunction: AD vs PD vs ALS vs FTD vs HD Comparis54%
related📖ALSINC Protein - ALS IncRNA54%
related📖ARO-MAPT-SC Tau ASO Trial (NCT07221344) - Arrowhead Pharmace54%
related📖c9orf72-als-ftd-phenotype-mechanism54%
related📖Relyvrio (Sodium Phenylbutyrate/Taurursodiol) for ALS54%
related📖Progressive Supranuclear Palsy (PSP) Pathway54%
related📖Motor Cortex in Amyotrophic Lateral Sclerosis54%
related📖CSF Biomarkers for Corticobasal Syndrome and Progressive Sup54%
related📖Axonal Transport Dysfunction in Progressive Supranuclear Pal54%
related📖Clinical Trials in Parkinson's Disease54%
related📖ALSENLITE: Senolytics for Alzheimer's Disease Trial54%
related📖Brain-Computer Interface for Progressive Supranuclear Palsy54%
related📖D-Cycloserine ALS Trial54%
related📖Dipeptide Repeat Proteins (DPRs) in C9orf72-ALS/FTD54%
related📖Tau Aggregate Specificity in Progressive Supranuclear Palsy54%
related📖Rehabilitation and Management of Progressive Supranuclear Pa54%
related📖ALS8 - Amyotrophic Lateral Sclerosis 854%
related📖JCR Pharmaceuticals54%
related📖C9orf72 Hexanucleotide Repeat Expansion Pathway in ALS54%
related📖Vestibular-Ocular Reflex Deficits in Progressive Supranuclea54%
related📖Astrocytes54%
related📖Master Screening Study to Determine Individuals With Potenti54%
related📖Mitochondrial Complex I Dysfunction in Progressive Supranucl54%
related📖Stress Granule Homeostasis in ALS/FTD54%
related📖FTLD-ALS: Frontotemporal Lobar Degeneration with Motor Neuro54%
related📖Pre-symptomatic Conversion Windows in ALS Genetic Risk Carri54%
related📖Spinal Cord Motor Neurons in Amyotrophic Lateral Sclerosis54%
related📖Veterinary Tauopathies in Progressive Supranuclear Palsy Res54%
related📖Lysosomal Dysfunction in Progressive Supranuclear Palsy54%
related📖Progressive Supranuclear Palsy Treatment Landscape54%
related📖Speech and Voice Disorders in Progressive Supranuclear Palsy54%
related📖PTPσ (PTPRS) in C9ORF72-ALS/FTD - PI3P Regulation Mechanism54%
related📖TDP-43 PET Ligand Development for FTD and ALS54%
related📖mitochondrial-dysfunction-als54%
related📖Progressive Supranuclear Palsy Neurons54%
related📖Myelin Pathology in Progressive Supranuclear Palsy54%
related📖progressive-supranuclear-palsy-tauopathy54%
related📖Local Field Potentials of Subthalamic Nucleus in Parkinson&#54%
related📖Tau Oligomer Biology in Progressive Supranuclear Palsy54%
related📖ALSINC — ALS IncRNA54%
related📖CBS/PSP Clinical Trials Guide54%
related📖Linked Clinical Trials (Cure Parkinson's)54%
related📖Investment Landscape: ALS54%
related📖Acoramidis Clinical Trials54%
related📖Motor Neurons in ALS and Frontotemporal Dementia54%
related📖Sargramostim (GM-CSF) ALS Trial54%
related📖Ion Channel Dysfunction in ALS54%
related📖C9orf72→RNA/Dipeptide Repeat Pathology→ALS/FTD — Causal Chai54%
related📖Tau Propagation and Seeding in Progressive Supranuclear Pals54%
related📖Rapamycin ALS Trial - mTOR Inhibition for Amyotrophic Latera54%
related📖SfN 2026: ALS and Motor Neuron Disease Sessions54%
related📖FUS Gene-Mechanism-Therapy Causal Chain — ALS/FTD54%
related📖ALS4 Protein (Alsin)54%
related📖Animal Models in Progressive Supranuclear Palsy Research54%
related📖Edaravone ALS Trial54%
related📖CHCHD10 Mitochondrial Dysfunction — ALS/FTD Causal Chain54%
related📖AAIC 2026: Prevention Trials54%
related📖Oculomotor Neurons in Amyotrophic Lateral Sclerosis54%
related📖Transcranial Magnetic Stimulation in Progressive Supranuclea54%
related📖atl1103-antisense-als54%
related📖ALS2 Protein (Alsin)54%
related📖FNP-223 PROSPER Trial - Phase 2 in Progressive Supranuclear 54%
related📖hypotheses54%
related📖AAN 2026 Clinical Trials54%
related📖CNversyt and Megan Rodden ALS Trials54%
related📖Metabolomic Alterations in Progressive Supranuclear Palsy54%
related📖Betz Cells in Amyotrophic Lateral Sclerosis54%
related📖Idebenone ALS Trial54%
related📖Acumen Pharmaceuticals, Inc.54%
related📖CTAD 2026 — Clinical Trials on Alzheimer's Disease54%
related📖Pain Syndromes in Progressive Supranuclear Palsy54%
related📖Environmental Risk Factors in Progressive Supranuclear Palsy54%
related📖FUS Protein-Targeting Therapy for ALS/FTD54%
related📖Ferroptosis Disease Comparison — AD/PD/ALS/FTD/HD54%
related📖scineuro-pharmaceuticals54%
related📖Masitinib ALS Trial54%
related📖Alsin Protein (ALS2)54%
related📖C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related📖Cognitive Impairment in Progressive Supranuclear Palsy54%
related📖Healthcare Economics and Cost of Illness in Progressive Supr54%
related📖Gabapentin ALS Trial54%
related📖Astrocyte Dysfunction: AD vs PD vs ALS vs FTD vs HD Comparis54%
related📖Blood-Brain Barrier Dysfunction: AD vs PD vs ALS Comparison54%
related📖Vertex Pharmaceuticals54%
related📖Alsin (ALSIN)54%
related📖biomarkers54%
related📖Treatment Approaches for Amyotrophic Lateral Sclerosis (ALS)54%
related📖Supernus Pharmaceuticals54%
related📖Ionis Pharmaceuticals54%
related📖Lithium Carbonate in Amyotrophic Lateral Sclerosis54%
related📖Vanda Pharmaceuticals54%
related📖Patricia Martinez — PSP Clinical Trials Researcher54%
related📖Metabolic Dysfunction and Insulin Resistance in Progressive 54%
related📖Imaging Biomarkers for Corticobasal Syndrome and Progressive54%
related📖Epigenetics in Amyotrophic Lateral Sclerosis54%
related📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy54%
related📖Lower Motor Neurons in ALS with C9orf7254%
related📖nimodipine-als54%
related📖Autonomic Dysfunction in Progressive Supranuclear Palsy54%
related📖PGC-1α Mitochondrial Biogenesis Comparison — AD/PD/ALS/FTD/H54%
related📖Anti-Amyloid Antibody Clinical Trials54%
related📖Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related📖ALS2 (Alsin)54%
related📖Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related📖Idorsia Pharmaceuticals Ltd.54%
related📖Noradrenergic Dysfunction in Progressive Supranuclear Palsy54%
related📖Inflammatory Astrocytes in ALS54%
related📖Astrocytes54%
related📖viral-post-infectious-als54%
related📖Valproic Acid Trial Failure in Progressive Supranuclear Pals54%
related📖Promising Clinical Trials in Neurodegenerative Diseases54%
related📖Heat Shock Protein Dysfunction in Progressive Supranuclear P54%
related📖mTOR Signaling Dysregulation in Progressive Supranuclear Pal54%
related📖C9orf72 Repeat Expansion in ALS54%
related📖Bulbar Palsy54%
related📖Tauraso (Nimodipine) ALS Trial54%
related📖experiments54%
related📖Araim Pharmaceuticals54%
related📖Locus Coeruleus Noradrenergic in Progressive Supranuclear Pa54%
related📖Neurovascular Coupling Disease Comparison — AD/PD/ALS/FTD/HD54%
related📖PD Clinical Trials — MDS 202654%
related📖Purinergic Receptor Targeted Trials in Parkinson's Dise54%
related📖Guam Parkinsonism-Dementia Complex (ALS-PDC)54%
related📖lgals3-protein54%
related📖FUS Proteinopathy Pathway in ALS54%
related📖Nacuity Pharmaceuticals54%
related📖Emerging Clinical Trials in Neurodegenerative Diseases54%
related📖Pyroptosis and Inflammasome Activation in Progressive Supran54%
related📖C9orf72 Hexanucleotide Repeat Expansion Pathway in ALS and F54%
related📖Environmental Exposure Causal Attribution in ALS — Experimen54%
related📖Speech and Swallowing Disorders in Progressive Supranuclear 54%
related📖mTOR Signaling Dysregulation in Progressive Supranuclear Pal54%
related📖BCI Clinical Trials for Neurodegenerative Diseases54%
related📖Progressive Supranuclear Palsy Investment Landscape54%
related📖Linked Clinical Trials Program54%
related📖Olfactory Dysfunction in Progressive Supranuclear Palsy54%
related📖Neuroimaging in Progressive Supranuclear Palsy54%
related📖glutamate54%
related📖Spinal Cord V2a Interneurons in ALS54%
related📖Progressive Supranuclear Palsy - Richardson Syndrome54%
related📖Progressive Supranuclear Palsy (PSP) Treatment Guide54%
related📖Lithium Continuation in ALS Trial54%
related📖SOD1-Targeting Therapies for ALS54%
related📖Typhaneoside for Progressive Supranuclear Palsy54%
related📖Anji Pharmaceuticals54%
related📖MitoRestore Pharmaceuticals54%
related📖Low-Dose Naltrexone ALS Trial54%
related📖Presynaptic Terminals in Neurodegeneration54%
related📖Shanghai Pharmaceuticals54%
related📖Neuroinflammation Comparison — AD/PD/ALS/FTD/HD54%
related📖Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related📖Ironwood Pharmaceuticals54%
related📖TDP-43 DNA Repair Mechanism in ALS and Dementia54%
related📖Exosome-Mediated Tau Propagation in Progressive Supranuclear54%
related📖Tau Aggregation Mechanisms in Progressive Supranuclear Palsy54%
related📖ER Stress and Unfolded Protein Response in Progressive Supra54%
related📖events54%
related📖Substantia Nigra Neurons in Progressive Supranuclear Palsy54%
related📖amiloride-als54%
related📖TDP-43 Pathology Reversibility in ALS54%
related📖Amyotrophic Lateral Sclerosis (ALS)54%
related📖Astrocytic Pathology in Progressive Supranuclear Palsy54%
related📖Brain Network Connectivity Changes in Progressive Supranucle54%
related📖Neuromelanin Loss in Progressive Supranuclear Palsy54%
related📖clinical-trials54%
related📖Cytoskeleton Dysfunction Comparison -- AD/PD/ALS/FTD/HD54%
related📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy54%
related📖als454%
related📖Pupillary and Visual Dysfunction in Progressive Supranuclear54%
related📖Progressive Supranuclear Palsy (PSP)54%
related📖Calcium Dysregulation in Progressive Supranuclear Palsy54%
related📖Sodium Phenylbutyrate/Taurursodiol (Relyvrio) for ALS54%
related📖ALSENLITE: Senolytics Trial for AD (NCT04785300)54%
related📖Mitochondria54%
related📖Intravenous Immunoglobulin (IVIG) in ALS Trial54%
related📖Subthalamic Nucleus Neurons in Progressive Supranuclear Pals54%
related📖Synaptic Dysfunction in Progressive Supranuclear Palsy54%
related📖Amylyx Pharmaceuticals, Inc.54%
related📖Gender Differences in Progressive Supranuclear Palsy54%
related📖Globus Pallidus Neurons in Progressive Supranuclear Palsy54%
related📖Alnylam Pharmaceuticals54%
related📖Vascular and Endothelial Dysfunction in Progressive Supranuc54%
related📖Mossy Fiber Terminals54%
related📖Motor Neuron Vulnerability in ALS54%
related📖TauRx Pharmaceuticals54%
related📖Iron Accumulation in Progressive Supranuclear Palsy54%
related📖Riluzole ALS Trials54%
related📖Non-Cell-Autonomous Glial Pathways in ALS54%
related📖Neuropsychiatric Symptoms in Progressive Supranuclear Palsy54%
related📖Creatine ALS Trial54%
related📖Lipid Metabolism Dysfunction Comparison — AD/PD/ALS/FTD/HD54%
related📖Sporadic ALS Initiation Mechanisms54%
related📖ALS9 - Amyotrophic Lateral Sclerosis 954%
related📖AAIC 2026: Clinical Trials and Drug Development54%
related📖Regeneron Pharmaceuticals54%
related📖Progressive Supranuclear Palsy54%
related📖Computational Tau Spreading Models in Progressive Supranucle54%
related📖VCP Proteostasis Modulation Therapy for ALS/FTD54%
related📖Cortical GABAergic Interneurons in Amyotrophic Lateral Scler54%
related📖Neural Circuits in Progressive Supranuclear Palsy54%
related📖OPTN (Optineurin) Mitophagy Dysfunction — ALS/FTD/PD Causal 54%
related📖Recursion Pharmaceuticals54%
related📖als254%
related📖CurePSP - Foundation for Progressive Supranuclear Palsy54%
related📖Nigrostriatal Dopamine Terminals in Parkinson Disease54%
related📖Edmond J Safra Accelerating Clinical Trials in Parkinson54%
related📖Neuroinflammation in Progressive Supranuclear Palsy54%
related📖Progressive Supranuclear Palsy (PSP) Treatment54%
related📖Sporadic ALS Initiation Mechanisms54%
related📖VCP→TDP-43→ALS/FTD Causal Chain54%
related📖Disease Progression and Staging in Progressive Supranuclear 54%
related📖FTD-ALS Spectrum54%
related📖LGALS1 Protein — Galectin-154%
related📖Circadian Dysfunction and Melatonin Alterations in Progressi54%
related📖Central Vestibular Pathway Vulnerability in Progressive Supr54%
related📖Brainstem Reflex Dysfunction in Progressive Supranuclear Pal54%
related📖Biomarkers for Progressive Supranuclear Palsy54%
related📖Sleep and Respiratory Network Interaction in ALS — Experimen54%
related📖Oligodendroglial Involvement in Progressive Supranuclear Pal54%
related📖C9orf72-ALS Network54%
related📖Clinical Trials in Progressive Supranuclear Palsy54%
related📖Pedunculopontine Nucleus Cholinergic in Progressive Supranuc54%
related📖Vascular Dementia Clinical Trials54%
related📖Sodium Phenylbutyrate ALS Trial54%
related📖Spinal Cord Astrocytes in ALS54%
related📖Proteomics of Progressive Supranuclear Palsy54%
related📖Ceftriaxone ALS Trial54%
related📖Spinal Cord Motor Neurons in Amyotrophic Lateral Sclerosis54%
related📖AMX0035 for Progressive Supranuclear Palsy54%
related📖Upper Motor Neurons in Amyotrophic Lateral Sclerosis54%
related📖Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
related📖Genetics of Progressive Supranuclear Palsy54%
related📖Myelin Pathology Disease Comparison — AD/PD/ALS/FTD/HD54%
related📖Neuropathology of Progressive Supranuclear Palsy54%
related📖Vestibular Dysfunction in Progressive Supranuclear Palsy54%
related📖Selective Neuronal Vulnerability in Progressive Supranuclear54%
related📖Proteasome Dysfunction in Progressive Supranuclear Palsy54%
related📖LGALS3 Gene54%
related📖Oligodendrocyte Dysfunction: AD vs PD vs ALS vs FTD vs HD Co54%
related📖Ocular Motor Dysfunction in Progressive Supranuclear Palsy54%
related📖Autophagy Dysfunction in Progressive Supranuclear Palsy54%
related📖ALS10 - Amyotrophic Lateral Sclerosis 10 (TARDBP)54%
related📖FNP-223 PROSPER Trial - Phase 2 in Progressive Supranuclear 54%
related📖Metabolic Pathway-Targeted Therapy in ALS54%
mentions📖PPAR Signaling Pathway in Neurodegeneration50%
mentions📖SPAM1: SIRT6 Positive Allosteric Modulator50%
mentions📖Section 194: Advanced Mitochondrial Dynamics and Biogenesis 50%
mentions📖PGC-1α Activator Therapy for Neurodegeneration50%
mentions📖Ventral Tegmental Area Dopamine Neurons in Neurodegeneration50%
mentions📖Sirtuin Modulators for Parkinson's Disease50%
mentions📖PGC-1α (PPARGC1A) Targeted Therapies in Neurodegeneration50%
mentions📖Cerebellar Interneurons in Neurodegeneration50%
mentions📖Medial Forebrain Bundle in Neurodegeneration50%
mentions📖NURR1 Agonist Therapy for Parkinson's Disease50%
mentions📖GDNF Family Neurotrophic Factor Signaling Pathway in Neurode50%
mentions📖Section 194: Advanced Mitochondrial Dynamics and Biogenesis 50%
mentions📖PGC-1α and Mitochondrial Biogenesis Therapies for Parkinson&50%
mentions📖Ferroptosis in Neurodegeneration50%
mentions📖ER Stress & UPR Therapeutics Investment Landscape44%
mentions📖MPTP-Induced Dopaminergic Neurons44%
mentions📖Heat Shock Protein (HSP) Therapeutics for Neurodegeneration44%
mentions📖Senolytic Therapeutics: Investment Landscape Analysis44%
mentions📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration44%
mentions📖AMPK-Mitochondrial Quality Control Axis44%
mentions📖Peptide Therapeutics for Neurodegeneration — Investment Land44%
mentions📖RNA Therapeutics: Investment Landscape Analysis44%
mentions📖Protein Aggregation Inhibitors for Neurodegeneration — Inves44%
mentions📖Exosome-Based Therapeutics for Neurodegenerative Diseases44%
mentions📖GLP-1 Receptor Agonist Therapeutics Investment Landscape44%
mentions📖4R Tauopathy Therapeutics — Investment Landscape Analysis44%
mentions📖Mitochondrial Therapeutics44%
mentions📖AD RNA-Based Therapeutics Companies44%
mentions📖Digital Therapeutics for Neurodegenerative Diseases44%
mentions📖Microbiome-Based Therapeutics for Neurodegeneration: Investm44%
mentions📖Adult Neurogenesis Therapeutics Investment Landscape44%
mentions📖Anti-Tau Therapeutics44%
mentions📖Lipid-Loaded Microglia (Foam Cells)44%
mentions📖Mitochondrial Biogenesis Inducers44%
mentions📖Anti-Amyloid Therapeutics: Successes, Failures, and Lessons 44%
mentions📖RNA Editing Therapeutics44%
mentions📖Mitochondrial Therapeutics Investment Landscape44%
mentions📖Lysosomal Dysfunction Therapeutics Investment Landscape44%
mentions📖Mitochondrial Quality Control44%
mentions📖Anti-Tau Therapeutics: Investment Landscape Analysis44%
mentions📖Genes44%
mentions📖AMPK Activators for Parkinson's Disease44%
mentions📖Irisin (FNDC5) - Exercise-Induced Myokine for Neurodegenerat44%
mentions📖Denali Therapeutics44%
mentions📖als40%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub